Learn more

CEREP SA

Overview
  • Total Patents
    23
About

CEREP SA has a total of 23 patent applications. Its first patent ever was published in 2001. It filed its patents most often in France, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and computer technology are KNUST HENNER, BOEHRINGER INGELHEIM PHARMACEUTICALS INC and ASHWELL MARK A.

Patent filings per year

Chart showing CEREP SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Balavoine Fabrice 11
#2 Potin Dominique 7
#3 Launay Michele 7
#4 Maillet Magali Jeannine Blandi 6
#5 Iwanowicz Edwin J 6
#6 Nicolai Eric Antoine 6
#7 Dhar T G Murali 5
#8 Nicolai Eric 5
#9 Rolland Catherine 4
#10 Batch Alexandre 4

Latest patents

Publication Filing date Title
FR2913019A1 New substituted heterocyclic compounds useful for treating/preventing cancer e.g. prostate, lung, breast, colon, skin, kidney and bone cancer, psoriasis, rheumatoid arthritis, Kaposis sarcoma, atherosclerosis and autoimmune diseases
FR2913016A1 Indole derivatives, benzimidazole or benzotriazole, comprising a piperidine or piperazine core, as anti-neoplastic agents or inhibitors of cell proliferation
FR2913017A1 New N-(substituted alkyl)-piperidine or piperazine derivatives, are cellular proliferation inhibitors useful e.g. for treating cancer or inflammatory or autoimmune diseases
FR2909376A1 Processes for preparing desmethulsertraline or one of its pharmaceutically acceptable salts
FR2909283A1 COMBINATION PRODUCT CONTAINING N-DESMETHYLSERTRALINE, OR ONE OF ITS SALT, AND AN ANNEOPLASTIC AGENT FOR THE TREATMENT OF CANCER
FR2900337A1 Use of alverine for the treatment of sexual dysfunctions
FR2894964A1 Compounds based on four aromatic cycles, preparation and uses
FR2889189A1 HYDANTOIN-DERIVED COMPOUNDS AND THEIR USE AS MCHR-1 ANTAGONISTS
FR2889191A1 COMPOUNDS DERIVED FROM 5-BENZYLIDENE IMIDAZOLIDINE 2,4-DIONE AND THEIR USE AS MCHR-1 ANTAGONISTS
FR2884516A1 Npy antagonists, preparation and uses
US7199125B2 Spiro-cyclic compounds useful as anti-inflammatory agents
FR2873293A1 Use of a fatty acid for the preparation of a topic composition for the saturation of inflammatory reactions due to venous hymenopter pensions
FR2869538A1 Use of alverine, alone or in combination with a tricyclic antidepressor or an inhibitory antidepressant specific to serotonin recapture for the treatment of low pressure
US6974815B2 Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
HU0400443A2 Pyrazolo[1,2-a][1,2,4]triazole compounds useful as anti-inflammatory agents and pharmaceutical compositions containing them
CA2436943A1 Hydantoin compounds useful as anti-inflammatory agents
EP1302866A1 Method of predicting biological activity profiles based on the neighborhood behavior of "in silico" similarity metrics calibrated with respect to activity spaces